De Vooght-Johnson Ryan
Future Science Group, London, UK.
Bioanalysis. 2011 Mar;3(6):579-91. doi: 10.4155/bio.11.40. Epub 2011 Mar 11.
An evening symposium was held at the Museu de Historia de Catalunya (Barcelona, Spain) as a precursor to the European Bioanalysis Forum meeting, as part of the Waters Corporation Bioanalysis World Tour. The symposium was chaired by Robert Plumb and Jing Lin (Waters Corporation, MA, USA) with a focus on the future of the DMPK laboratory and its role in addressing large-molecule therapeutics and biomarkers. Lieve Dillen (Johnson and Johnson, Belgium) spoke on ultra-sensitive peptide quantification, Richard Kay (Quotient Bioresearch, UK) discussed quantifying proteins and peptides in plasma, Ian Wilson (AstraZeneca, UK) covered metabolic biomarkers and Robert Plumb concluded the evening with a presentation on the future of MS in DMPK studies. Following the presentations, all the speakers took questions from the audience and continued lively discussion over a cocktails and canapés reception.
作为沃特世公司生物分析世界巡回活动的一部分，一场晚间研讨会在加泰罗尼亚历史博物馆（西班牙巴塞罗那）举行，作为欧洲生物分析论坛会议的前奏。该研讨会由罗伯特·普拉姆和林静（美国马萨诸塞州沃特世公司）主持，重点讨论药物代谢动力学（DMPK）实验室的未来及其在应对大分子疗法和生物标志物方面的作用。利夫·迪伦（比利时强生公司）就超灵敏肽定量进行了发言，理查德·凯（英国商数生物研究公司）讨论了血浆中蛋白质和肽的定量，伊恩·威尔逊（英国阿斯利康公司）介绍了代谢生物标志物，罗伯特·普拉姆以关于DMPK研究中质谱未来的演讲结束了当晚的活动。演讲结束后，所有演讲者回答了观众的提问，并在鸡尾酒会和小吃招待会上继续进行了热烈的讨论。
